Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
2005
Predominant Autoantibody Production by Early Human B Cell Precursors
2003 StandoutScience
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
2008
Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
2010
The German etanercept registry for treatment of juvenile idiopathic arthritis
2004
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Inflammation and cancer
2002 StandoutNature
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
2004
Medical Treatment of Juvenile Idiopathic Arthritis
2005
Frequency of VH-gene utilization in human EBV-transformed B-cell lines: The most JH-proximal VH segment encodes autoantibodies
1989
Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas
2004
Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome
2004
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
2003
Manipulating the Immune System with Immune Globulin
1992
Use of the sharp and larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis
2006
Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis
2007
A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
2005
Worsening of Macrophage Activation Syndrome in a Patient with Adult Onset Still’s Disease after Initiation of Etanercept Therapy
2001
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
2008
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
2009
National Institutes of Health Center for Human Immunology Conference, September 2009
2010
Taking advantage of luminescent lanthanide ions
2005 Standout
Differentiating the efficacy of the tumor necrosis factor inhibitors
2005
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Etanercept in the treatment of adult patients with Still's disease
2002
Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
2009
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
2007
International research networks in pediatric rheumatology: the PRINTO perspective
2004
Guillain-Barré syndrome
2016 Standout
Juvenile idiopathic arthritis
2007 Standout
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Common variable immunodeficiency: a new look at an old disease
2008
Radiologic Investigation of Rheumatic Diseases
2007
Treatment of Multicentric Reticulohistiocytosis With Etanercept
2004
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)
2002
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long‐term followup study
2007
Pharmacokinetic and Tolerability Assessment of a Pediatric Oral Formulation of Pentoxifylline in Kawasaki Disease
2003
Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen
1987
Mucosal immunity and vaccines
2005 Standout
Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease
2002
Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
2006
Long‐term open‐label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular‐course juvenile rheumatoid arthritis
2005
Biologic Agents for the Treatment of Juvenile Rheumatoid Arthritis
2004
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Sarcoidosis
2013 Standout
Myasthenia Gravis
1994 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects
2002
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
2003
Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
2004
Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis
2005
Psoriasis: emerging therapeutic strategies
2005
Graves' Ophthalmopathy
2010 Standout
Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy
2005
Etanercept and uveitis in patients with juvenile idiopathic arthritis
2005
Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
1991
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
2009
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
2007
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Recalcitrant, Recurrent Aphthous Stomatitis Treated With Etanercept
2003
Physical map of the 3′ region of the human immunoglobulin heavy chain locus: clustering of autoantibody-related variable segments in one haplotype.
1991 StandoutNobel
Ankylosing spondylitis
2007 Standout
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
2006
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
2001 Standout
Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis
2004
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis
2004
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
1992 StandoutNobel
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
2009
Highly Sensitive Time-Resolved Fluoroimmunoassay of Human Immunoglobulin E by Using a New Europium Fluorescent Chelate as a Label
1997
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
2008
TNF-α targeted therapeutic approaches in patients with hematologic malignancies
2002
Adalimumab in the therapy of uveitis in childhood
2006
Etanercept
2002
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Autoantibodies and the Fetal Antibody Repertoire
1990
Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis
2003
Lymphocytes activated by the epstein‐barr virus to produce immunoglobulin do not express CD23 or become immortalized
1988
Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositis
2002
Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets
2016 Standout
The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops
1992 StandoutNobel
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
2008
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Salicylate treatment in Kawasaki disease: high dose or low dose?
1991
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Safety of Tumour Necrosis Factor-?? Antagonists
2004
Tumour Necrosis Factor in Sarcoidosis and its Potential for Targeted Therapy
2003
Therapeutic Approaches in Multiple Sclerosis
2002
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
2002
Dermatomyositis
2000
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
2003
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
2004
Development of anti-TNF therapy for rheumatoid arthritis
2002
Evidence-Based Knee Injections for the Management of Arthritis
2012
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)‐Fc fusion protein in patients with myelodysplastic syndrome
2002
Arthritis presenting during the acute phase of Kawasaki disease
2006
Current management of juvenile idiopathic arthritis
2006
Sarcoidosis
2007 Standout
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: Introduction of the Dijkstra composite score
2005
Human T Cell Development, Localization, and Function throughout Life
2018
Polymyositis and dermatomyositis
2003 Standout
Knee in Early Juvenile Rheumatoid Arthritis: MR Imaging Findings
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Etanercept therapy in children with treatment-resistant uveitis
2001
Systemic effects of chronic obstructive pulmonary disease
2003
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
2002
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
2004
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
2005
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
2008
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes
2002
Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease
2010
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations
2012
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Inflammatory Muscle Diseases
2015 Standout
Etanercept for Refractory Ocular Sarcoidosis
2005
TNF-R1 Signaling: A Beautiful Pathway
2002 StandoutScience
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.
2004
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab
2006
Nocardiosis Associated with a Giant Pleurolith Secondary to a Long-standing Oleothorax
1967
Association of Prior Nocardiosis and Subsequent Occurrence of Nontuberculous Mycobacteriosis in a Defined, Immunosuppressed Population
1982
A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept
2002
Update on Spondyloarthropathies
2002
Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis.
2005
Arthritis and uveitis in children
2003
Polyspecific natural antibodies and autoantibodies secreted by human lymphocytes immortalized with Epstein-Barr virus
1988
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Long-term Consequences of Kawasaki Disease
1996 Standout
Nocardia species: host-parasite relationships
1994 Standout
Salicylate for the treatment of Kawasaki disease in children
2006
A case of disseminated nocardiosis
1968
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Purulent Constrictive Pericarditis Caused by Nocardia asteroides
1967
Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
2005
Current Treatment of Juvenile Rheumatoid Arthritis
2002
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development
2006 StandoutNobel
Pulmonary alveolar proteinosis. Review of the literature with follow-up studies and report of two new cases.
1966
Works of Leonard D. Stein being referenced
Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids
1999
Long‐term safety and efficacy of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis
2006
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
2000
Determinants of low serum concentrations of salicylates in patients with Kawasaki disease
1988
Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial
2003
Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis
1990
Autoantibodies to DEK oncoprotein in human inflammatory disease
2000
Gingival Telangiectases
1999
IgE-enhancing activity directly and selectively affects activated B cells: evidence for a human IgE differentiation factor.
1987
The camptodactyly‐arthropathy‐pericarditis syndrome: Case report and literature review
1986
Lymphocyte abnormalities and complement activation in Kawasaki disease.
1987
Clinical significance of specific autoantibodies in juvenile dermatomyositis.
1996
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients
2003
NOCARDIOSIS AND TUBERCULOSIS
1962
Heterogeneity of EBV-transformable human B lymphocyte populations.
1986
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease
1985